Search

everythinglearnresearchcommunity

for

Search:↓

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Activating β-catenin in certain skin cells speeds up hair growth in mice.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

The enzyme PST is found in developing human kidneys and helps with detoxification and development.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Adding more glutathione to the preservation solution doesn't reduce oxidative stress in hair transplants.

Severe hair loss links to metabolic issues in older men with psoriasis.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Autophagy prevents early aging and maintains lipid and pheromone balance in mouse glands.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.